Some reports are about the way a product was used, not only about a reaction. The rules:
- Overdose. ICH E2D says an overdose with no adverse outcome is not reported as an adverse reaction, but the company collects the information. An overdose with a serious reaction is reported like any serious case.
- Medication errors (the wrong drug or dose given or taken) are safety information under ICH E2D(R1), including near misses caught before reaching the patient, which regions may want reported.
- Lack of efficacy is usually discussed in periodic reports, not expedited, except for products used for life-threatening or serious diseases, vaccines and contraceptives, where it should be considered for expedited reporting.
- Pregnancy. Every report of exposure during pregnancy is followed up for the outcome, even with no event yet.
- Off-label use (for a use, dose or patient group the label does not cover) is judged against the local label; with an adverse event it is a case like any other.
FDA's own definition of an adverse drug experience (21 CFR 314.80) names overdose, drug abuse, drug withdrawal and any failure of the expected pharmacological action.